{"id":"https://openalex.org/W4283661824","doi":"https://doi.org/10.1097/mog.0000000000000854","title":"Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice","display_name":"Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice","publication_year":2022,"publication_date":"2022-06-28","ids":{"openalex":"https://openalex.org/W4283661824","doi":"https://doi.org/10.1097/mog.0000000000000854","pmid":"https://pubmed.ncbi.nlm.nih.gov/35762693"},"language":"en","primary_location":{"id":"doi:10.1097/mog.0000000000000854","doi":"https://doi.org/10.1097/mog.0000000000000854","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mog.0000000000000854","pdf_url":null,"source":{"id":"https://openalex.org/S41211651","display_name":"Current Opinion in Gastroenterology","issn_l":"0267-1379","issn":["0267-1379","1531-7056"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021465331","display_name":"Dhruv Ahuja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dhruv Ahuja","raw_affiliation_strings":["Department of Medicine, Janakpuri Super Specialty Hospital, New Delhi, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Janakpuri Super Specialty Hospital, New Delhi, New Delhi, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035847062","display_name":"Siddharth Singh","orcid":"https://orcid.org/0000-0002-2640-7269","observed_orcids":["https://orcid.org/0000-0002-2640-7269","https://orcid.org/0000-0002-1388-6221"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Siddharth Singh","raw_affiliation_strings":["Division of Biomedical Informatics, Department of Medicine, UC San Diego, La Jolla, California, USA","Division of Gastroenterology","fax: +1 858 657 7259","to Siddharth Singh, MD, MS, Associate Professor of Medicine, Division of Gastroenterology, and Division of Biomedical Informatics, Department of Medicine, Director, IBD Center, University of California San Diego, 9452 Medical Center Drive, ACTRI 1W501, La Jolla, CA 92037, USA. Tel: +1 858 246 2352"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biomedical Informatics, Department of Medicine, UC San Diego, La Jolla, California, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Division of Gastroenterology","institution_ids":[]},{"raw_affiliation_string":"fax: +1 858 657 7259","institution_ids":[]},{"raw_affiliation_string":"to Siddharth Singh, MD, MS, Associate Professor of Medicine, Division of Gastroenterology, and Division of Biomedical Informatics, Department of Medicine, Director, IBD Center, University of California San Diego, 9452 Medical Center Drive, ACTRI 1W501, La Jolla, CA 92037, USA. Tel: +1 858 246 2352","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035847062"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":null,"apc_paid":null,"fwci":0.4583,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.43583043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"38","issue":"4","first_page":"337","last_page":"346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":1.0},{"id":"https://openalex.org/keywords/vedolizumab","display_name":"vedolizumab","score":0.8880000114440918},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.8029999732971191},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/biosimilar-infliximab","display_name":"infliximab biosimilar","score":0.9139999747276306},{"id":"https://openalex.org/keywords/network-meta-analysis","display_name":"network meta-analysis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.875},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.8610000014305115},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.881365180015564},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.7918084859848022},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7324395179748535},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6718798279762268},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.6700438261032104},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6680399179458618},{"id":"https://openalex.org/C2776207728","wikidata":"https://www.wikidata.org/wiki/Q7918002","display_name":"Vedolizumab","level":4,"score":0.6574198603630066},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5966686010360718},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.5669633150100708},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.48051130771636963},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.4792878031730652},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.460908979177475},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4244231879711151},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4047551155090332},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35348400473594666}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/mog.0000000000000854","doi":"https://doi.org/10.1097/mog.0000000000000854","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mog.0000000000000854","pdf_url":null,"source":{"id":"https://openalex.org/S41211651","display_name":"Current Opinion in Gastroenterology","issn_l":"0267-1379","issn":["0267-1379","1531-7056"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Gastroenterology","raw_type":"journal-article"},{"id":"pmid:35762693","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35762693","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in gastroenterology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6299999952316284,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2921157762","display_name":"Predicting Short- and Long-term Risk of Serious Infections in Older Patients with Inflammatory Bowel Diseases","funder_award_id":"R03DK129631","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G5951918226","display_name":"Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel Diseases","funder_award_id":"K23DK117058","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1573555636","https://openalex.org/W1967188199","https://openalex.org/W1975391202","https://openalex.org/W2011840006","https://openalex.org/W2014453502","https://openalex.org/W2040557955","https://openalex.org/W2071806619","https://openalex.org/W2082081076","https://openalex.org/W2098254123","https://openalex.org/W2111362292","https://openalex.org/W2126807394","https://openalex.org/W2146785136","https://openalex.org/W2492888198","https://openalex.org/W2613299853","https://openalex.org/W2617461034","https://openalex.org/W2726405642","https://openalex.org/W2761854305","https://openalex.org/W2886144609","https://openalex.org/W2921183574","https://openalex.org/W2923675504","https://openalex.org/W2946172582","https://openalex.org/W2948630456","https://openalex.org/W2976731348","https://openalex.org/W2999797317","https://openalex.org/W3000124921","https://openalex.org/W3000586022","https://openalex.org/W3016864895","https://openalex.org/W3026023260","https://openalex.org/W3164828618","https://openalex.org/W3165093433","https://openalex.org/W3165463838","https://openalex.org/W3165747682","https://openalex.org/W3168298113","https://openalex.org/W3186412928","https://openalex.org/W3189891106","https://openalex.org/W3194378390","https://openalex.org/W3210657561","https://openalex.org/W3212891161","https://openalex.org/W3213907938","https://openalex.org/W4200306050","https://openalex.org/W4205374244","https://openalex.org/W4210258765","https://openalex.org/W6796301597","https://openalex.org/W7074209992"],"related_works":["https://openalex.org/W7126056221","https://openalex.org/W3149835957","https://openalex.org/W3042728423","https://openalex.org/W7161158616","https://openalex.org/W7204943722","https://openalex.org/W3147778037","https://openalex.org/W7171056070","https://openalex.org/W3016864895","https://openalex.org/W3111981191","https://openalex.org/W3165140169"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Over":[3],"the":[4,13,22,63,184],"last":[5],"decade,":[6],"there":[7,30],"has":[8],"been":[9],"rapid":[10],"expansion":[11],"of":[12,18,24,45,68,86,106,120,125,132,168,173,186],"therapeutic":[14],"armamentarium,":[15],"and":[16,47,66,101,130,158,166,193,202,222],"evolution":[17],"treatment":[19,51,55,150],"strategies,":[20],"for":[21,35,90,171,206],"management":[23,172],"inflammatory":[25],"bowel":[26],"diseases":[27],"(IBDs).":[28],"Consequently,":[29],"is":[31],"an":[32],"increasing":[33],"need":[34],"head-to-head":[36],"or":[37,141,209],"comparative":[38,69,164,216],"efficacy":[39,70,131,189],"trials":[40,49,72,82,119,157,178,190],"to":[41,53,103,182,195,215,230],"inform":[42,54,163],"optimal":[43],"positioning":[44],"therapies,":[46],"pragmatic":[48],"comparing":[50],"strategies":[52],"approach.":[56],"In":[57],"this":[58],"review,":[59],"we":[60],"will":[61],"discuss":[62],"current":[64],"status":[65],"future":[67],"clinical":[71,81,92,118,177,234],"in":[73,94,110,128,233],"IBD.":[74,174,187],"RECENT":[75],"FINDINGS:":[76],"Pivotal":[77],"phase":[78],"IIIB":[79],"superiority":[80,85,105],"have":[83,122,162],"demonstrated":[84],"vedolizumab":[87],"over":[88,108,135],"adalimumab":[89,109],"achieving":[91],"remission":[93],"patients":[95,111,144],"with":[96,112],"moderate-to-severe":[97,113],"ulcerative":[98],"colitis":[99],"(VARSITY)":[100],"failed":[102],"demonstrate":[104],"ustekinumab":[107],"Crohn's":[114],"disease":[115],"(SEAVUE).":[116],"Noninferiority":[117],"biosimilars":[121],"confirmed":[123],"absence":[124],"meaningful":[126],"differences":[127],"safety":[129,167,207],"biosimilar":[133],"infliximab":[134],"originator":[136],"infliximab,":[137],"as":[138,219],"initial":[139],"therapy":[140],"switching":[142],"stable":[143],"during":[145],"maintenance.":[146],"Network":[147],"meta-analyses,":[148],"indirect":[149],"comparison":[151],"using":[152],"patient-level":[153],"data":[154],"from":[155],"placebo-controlled":[156],"real-world":[159,225],"observational":[160,226],"studies":[161,227],"effectiveness":[165,217],"different":[169],"therapies":[170],"SUMMARY:":[175],"Head-to-head":[176],"are":[179,191,203,228],"critically":[180],"important":[181],"advance":[183],"field":[185],"Comparative":[188],"slow":[192],"expensive":[194],"conduct,":[196],"may":[197],"not":[198,204],"be":[199],"broadly":[200],"generalizable,":[201],"powered":[205],"events":[208],"other":[210],"relevant":[211],"outcomes.":[212],"Alternative":[213],"approaches":[214],"such":[218],"network":[220],"meta-analysis":[221],"well":[223],"designed":[224],"able":[229],"bridge":[231],"gaps":[232],"practice.":[235]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-06-29T00:00:00"}